NASDAQ
MabCure, Inc. (MBCI) has a price/sales ratio of 8.92x as of Monday, May 25, 2026. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.